Overview


According to FutureWise analysis, the market for Animal Auto-Immune Disease Diagnostics  is expected to grow at a CAGR of 5.52% over the forecast period of 2023-2031.

Animal autoimmune disease diagnostics involve identifying and diagnosing autoimmune diseases in animals. Autoimmune diseases occur when an animal's immune system falsely attacks its own cells and tissues, leading to various health issues and inflammation. The treatment will depend on the type of autoimmune disease being addressed and typically involves one or more medications to suppress the immune system. The aim here is to weaken the immune system and thus stop it from attacking the body. Over time, attempts are made to gradually reduce an animal's medication, hoping its immune system will function normally. However, this process can be dangerous, and managing an autoimmune disease usually involves lifelong care. Even if the animal is successfully weaned off medication, the potential for flare-ups means continual monitoring throughout its life is necessary.

The exact cause of autoimmune diseases remains unclear, but theories suggest a connection between genetics and exposure to environmental pollutants. In some animals, autoimmune skin diseases can be triggered by factors like ultraviolet exposure or certain medications, particularly in the case of pemphigus foliaceus. Early detection of autoimmune diseases is crucial because, if left untreated, it may lead to severe complications, often affecting multiple systems in the body. This complexity makes diagnosing and treating these conditions a challenging and intricate process.

FutureWise Market Research has published a report that provides an insightful analysis Animal Auto-Immune Disease Diagnostics Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, Animal Auto-Immune Disease Diagnostics Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Elabscience Biotechnology Co. Ltd
  • IDEXX Laboratories
  • VCA, Inc.
  • ABAXIS, Inc.
  • Heska Corporation
  • Zoetis, Inc.
  • Accuplex Diagnostics
  • ID Vet
  • Neogen Corporation
  • Thermo fisher Scientific, Inc.
  • Mindray Medical Internationals Ltd.
  • GE Healthcare
  • Agfa Healthcare

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Animal Auto-Immune Disease Diagnostics Market:

  • In August 2022, KSL Beutner Laboratories (Beutner) introduced a groundbreaking blood test capable of detecting an antigen associated with mucous membrane pemphigoid (MMP), an autoimmune blistering disease known to cause painful lesions in the oral cavity. This innovative test represents a significant advancement in the diagnosis and management of MMP.
  • In May 2022, The new Phadia 2500+ series of instruments by Thermofisher will be available for autoimmune testing in the United States. It offers reliable and unparalleled high throughput for both allergy diagnostics and autoimmune testing.

The increasing occurrences of auto-immune diseases in animals are expected to drive the growth of the animal auto-immune disease diagnostics market during the forecast period. As pet ownership continues to grow, coupled with improved awareness and advancements in veterinary medicine, the prevalence of auto-immune conditions in animals has increased. Pet owners are now more inclined to seek an early and accurate diagnosis of such diseases to ensure timely and effective treatment, propelling the demand for advanced diagnostic tools and technologies in the market. Additionally, the rising focus on animal welfare and timely disease detection among veterinarians further contributes to the market's expansion as they seek reliable and efficient diagnostic solutions to address these auto-immune challenges in companion animals and livestock. Furthermore, the limited intervention by the government to promote the clinical diagnosis of animal auto-immune diseases poses a significant barrier to the Animal Auto-Immune Disease Diagnostics Market. In the absence of proactive government support and incentives, veterinary clinics and diagnostic laboratories may face challenges in adopting advanced diagnostic technologies and investing in research and development for improved diagnostics. Moreover, the lack of standardized guidelines and regulations for animal auto-immune disease diagnostics may result in varying diagnostic accuracy and reliability levels, hindering market growth and potentially limiting the accessibility of these crucial diagnostic services to a broader population of pet owners and livestock farmers.

By Test Type

  • Complete Blood Count
  • Thyroid test
  • Biopsy Test
  • Urinalysis
  • DNA Amplification Test
  • Immunoassays Test

By Indication

  • Hypothyroidism
  • Pemphigus Disease
  • Canine Lupus
  • Auto-Immune Hemolytic Anemia
  • Bullous Pemphigoid
  • Discoid Lupus Erythematosus (DLE)
  • Autoimmune hemolytic anemia
  • Immune-related arthritis
  • Others

By Animal Type

  • Companion Animal
    • Dogs
    • Cats
    • Horse
  • Live Stock Animal
    • Cattle
    • Swine
    • Poultry
    • Fish
    • Sheep

By End User

  • Veterinary Hospital
  • Veterinary Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The dominant market share of North America can be attributed to several factors, including substantial healthcare expenditure, a high incidence of autoimmune diseases, growing patient awareness regarding these conditions, and a notable increase in funding and investments dedicated to research and development in the field of autoimmune diseases. Also, due to higher awareness of threats of zoonotic disease transfer, the availability of veterinary care facilities is bridging pet and human health concerns. The factors mentioned above are expected to drive market growth during the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Animal Auto-Immune Disease Diagnostics Market By Test Type, By Indication, By Animal Type, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Auto-Immune Disease Diagnostics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Auto-Immune Disease Diagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Auto-Immune Disease Diagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Auto-Immune Disease Diagnostics Market, By Test Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Complete Blood Count
        2. Thyroid test
        3. Biopsy Test
        4. Urinalysis
        5. DNA Amplification Test
        6. Immunoassays Test

  • 8.   Animal Auto-Immune Disease Diagnostics Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hypothyroidism
        2. Pemphigus Disease
        3. Canine Lupus
        4. Auto-Immune Hemolytic Anemia
        5. Bullous Pemphigoid
        6. Discoid Lupus Erythematosus (DLE)
        7. Autoimmune hemolytic anemia
        8. Immune-related arthritis
        9. Others

  • 9.   Animal Auto-Immune Disease Diagnostics Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Companion Animal
         1.1. Dogs
         1.2. Cats
         1.3. Horse
        2. Live Stock Animal
         2.1. Cattle
         2.2. Swine
         2.3. Poultry
         2.4. Fish
         2.5. Sheep

  • 10.   Animal Auto-Immune Disease Diagnostics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Veterinary Hospital
        2. Veterinary Clinics

  • 11.   North America Animal Auto-Immune Disease Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Animal Auto-Immune Disease Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Animal Auto-Immune Disease Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Animal Auto-Immune Disease Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Animal Auto-Immune Disease Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Elabscience Biotechnology Co. Ltd
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. IDEXX Laboratories
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. VCA, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. ABAXIS, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Heska Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Zoetis, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Accuplex Diagnostics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. ID Vet
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Neogen Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Thermo fisher Scientific, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Mindray Medical Internationals Ltd.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. GE Healthcare
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Agfa Healthcare
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Related Market

Animal Auto-Immune Disease Therapeutics Market

Read More
Partner

Our Clients